Menu
Global B2B sourcing platform
Verified suppliers and manufacturers

API Pharmaceutical Intermediate CAS 137234-62-9 Best Price Voriconazole Powder

Price $65.00
Min Order 1 kg
Availability In Stock
Shipping From Shaanxi, China
Popularity 282 people viewed
Model NO.:
HMJ
Product Name:
Voriconazole
CAS:
137234-62-9
Color:
White
MOQ:
1kg
Form:
Powder
Delivery:
Express 5-7 Days Arrive
Grade:
Medicine Grade
Package:
1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
Trademark:
HMJ
Transport Package:
Foil Bag/Drum
Specification:
99%
Origin:
China
Product Description

Product Description

              API Pharmaceutical Intermediate CAS 137234-62-9 Best Price Voriconazole Powder  

Product description:

  Voriconazole is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of progressive, possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genus and Fusarium bacteria genus . Moderate to severe renal insufficiency is administered intravenously paying caution.

Function of Voriconazole:

1. Voriconazole is a triazole antifungal medication, it can cure empirical antifungal therapy.
2. Voriconazole has become the new standard of care in the treatment of invasive aspergillosis.
3. Voriconazole can used in the treat of esophageal candidiasis.
4. Voriconazole has also been used to treat severe fungal corneal infection.
5. An antifungal (systemic). An ergosterol biosynthesis inhibitor...


Application of Voriconazole:

Voriconazole is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of progressive, possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genus and Fusarium bacteria genus . Moderate to severe renal insufficiency is administered intravenously paying caution.


  • Similar Products
Full Page Contact Supplier